氧化,氧化碳胺和迪达诺辛作为艾滋病毒-1的经济治疗方法
Nicholas I Paton1, Jamila Aboulhab, Fatimah Karim
1Department of Infectious Diseases, Tan Tock Seng Hospital, 308433, Singapore. Paton_NIJ@ttsh.com.sg
Lancet (London, England)
|May 22, 2002
概括
一种新的,负担得起的HIV-1治疗方法,结合氧化,氧尿素和迪达诺辛,对资源有限的环境有很大的希望. 组合疗法耐受性良好,有效降低病毒载量,同时保持HIV-1患者的CD4计数.
科学领域:
- 传染性疾病 传染性疾病
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于HIV-1的标准组合抗逆转录病毒疗法 (cART) 在许多低资源国家是负担不起的.
- 全球急需经济有效的HIV-1治疗替代方案.
研究的目的:
- 评估一种新且具有成本效益的HIV-1治疗药物组合的安全性和有效性.
- 评估接受新疗程的HIV-1患者的病毒载荷减少和CD4计数变化.
主要方法:
- 总共有22名HIV-1感染患者,具有特定的病毒载量和CD4计数标准被纳入.
- 患者每天两次接受氧化 (200毫克),氧化碳胺 (500毫克) 和迪达诺辛 (125-200毫克) 的治疗方案.
- 治疗结果在48周内进行评估,重点关注16名可评估患者的病毒载量和CD4细胞计数.
主要成果:
- 药物组合耐受性良好,严重不良事件发生率低.
- 在可评估患者中观察到持续的病毒载荷下降1.3log.
- 维持了CD4细胞计数,在48周的研究期间显示2.9%的增加.
结论:
- 这种氧化,氧化碳胺和迪达诺辛的组合为资源有限的国家提供了潜在的合适和经济的HIV-1治疗选择.
- 需要进一步的研究来验证这些发现,并探索更广泛的临床应用.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...


